Consequently, increased fibronectin deposition and fibronectin expression in fibroblasts have been described in various pathological conditions of the lung, including idiopathic pulmonary fibrosis (IPF), COPD, and cancer [37, 50, 62, 120]. This evidence concerns the gene FN1 and cancer.